← FDA Drug Approvals (Drugs@FDA)
NINTEDANIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE INC · Approved 2020-08-04
Drug application
- FDA Application #
ANDA212732- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NINTEDANIB
- Generic name
- Nintedanib
- Active ingredients
- NINTEDANIB
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- ACCORD HLTHCARE INC
- First approval
- 2020-08-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown